Merck’s press conference was very disappointing, according to Andy Birchfield, who manages the Mass Torts Section at Beasley, Allen, Methvin Portis & Miles. “Instead of accepting responsibility for putting a dangerous drug on the market and keeping it there for so long, Merck spent an hour defending itself.” 

“Merck could have been more conciliatory and offered an apology to the many victims who suffered heart attacks and strokes and to the families of victims who died as a result of Vioxx,” Birchfield says. “But Merck continued to spin their actions as that of a responsible pharmaceutical company.”

Merck stated that it moved quickly to do what was best for patients. “But we know differently,” Birchfield says.

When confronted with early warning signs of the dangers of Vioxx, Merck did not pull back on Vioxx until questions about risks could be answered. On the contrary, Merck kept its massive marketing effort going full speed. “This clearly belies Merck’s suggestion that it acted responsibly and with a commitment to patient safety,” Birchfield adds.

Perhaps, the clearest and most disturbing indication of Merck putting Vioxx sales over patient safety is seen in what Merck did one week after the FDA’s observational study showed a 315% increase risk in heart attacks and sudden cardiac deaths over Celebrex: Merck obtained approval to market Vioxx to children!

Beasley Allen is recognized as a national leader in pharmaceutical litigation. Currently, the firm’s Mass Torts Section is handling cases involving Baycol, Rezulin, Vioxx, Celebrex, PPA, Ephedra, Welding Rods, Metabolife and Meridia.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Merck to pay $830 million to settle investors’ Vioxx...

Merck announced Friday it will pay $830 million to settle investor complaints accusing it of committing...

Merck to pay nearly $1 billion for illegal marketing...

American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal...

Merck paying more than 3,100 vioxx death claims

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who...

Settlement limits insurers' claims in Vioxx deal

TRENTON, N.J. (AP) -- Former Vioxx users getting part of a $4.85 billion settlement ending most personal...

Persistence pays in Vioxx litigation

Plaintiffs get close to $5B, but Merck could have done a lot worse. Attorneys who spent nearly one year...

Vioxx settlement payments to begin in August

Merck & Co., manufacturer of Vioxx, announced it will make the first payment of $500 million on Aug....

Excellent law firm

Beasley Allen is an excellent law firm. I highly recommend their services.

—William M.